This finding correlates with data showing that these genes (positively regulated by HPRT1) are more highly expressed in basal type ER- patient tumor samples, and when compared to ER+ tumor types (Figure 4A) have lower DMFS, and poorer clinical outcome (Figure 4B). This evidence concerns the gene HPRT1 and neoplasm.